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ABSTRACT
19F NMR spectroscopy has proved to be a valu-
able tool to monitor functionally important con-
formational transitions of nucleic acids. Here, we
present a systematic investigation on the applica-
tion of 5-fluoro pyrimidines to probe DNA and RNA
secondary structures. Oligonucleotides with the
propensity to adapt secondary structure equilibria
were chosen as model systems and analyzed by
1D
19F and
1H NMR spectroscopy. A comparison
with the unmodified analogs revealed that the equi-
librium characteristics of the bistable DNA and RNA
oligonucleotides were hardly affected upon fluorine
substitution at C5 of pyrimidines. This observation
was in accordance with UV spectroscopic melting
experiments which demonstrated that single
5-fluoro substitutions in double helices lead to
comparable thermodynamic stabilities. Thus, 5-
fluoro pyrimidine labeling of DNA and RNA can be
reliably applied for NMR based nucleic acid second-
ary structure evaluation. Furthermore, we developed
a facile synthetic route towards 5-fluoro cytidine
phosphoramidites that enables their convenient
site-specific incorporation into oligonucleotides by
solid-phase synthesis.
INTRODUCTION
The use of ﬂuorine labels in context with NMR spectros-
copy represents an emerging tool to study structure
and function of nucleic acids (1–3). In contrast to
1H
NMR spectroscopy, the problem of resonance degeneracy
is practically absent for
19F NMR spectroscopy.
Together with the option to site-speciﬁcally incorporate
ﬂuorine labels into DNA and RNA and thus to avoid
time-consuming signal assignment procedures, these
advantages can be exploited to monitor conformational
changes and folding of nucleic acids or to investigate
binding processes in small molecule/nucleic acid or
enzyme/nucleic acid complexes. This was demonstrated
with short oligonucleotides (4–17) but also with transfer
RNAs (18,19), ribozymes (20), RNA aptamers (21),
or with substrates of DNA methyltransferases (22), to
mention a few examples.
Concerning the position of labeling, ﬂuorine
modiﬁcations at both the ribose and the nucleobase unit
come into consideration (Figure 1). The majority of
19F
NMR studies on nucleic acids have involved 5-ﬂuoro
uracil so far which is easily accessible as nucleoside
phosphoramidite either for solid phase synthesis of
DNA or RNA (6,23), or as nucleoside triphosphate deriv-
ative for enzymatic RNA synthesis by T7 polymerase
(18,19,24,25). Signiﬁcantly less studies deal with 5-ﬂuoro
cytosine in nucleic acids (22,24–27). A comprehensive and
comparative study on the usage of both 5-ﬂuoro uracil
and 5-ﬂuoro cytosine as potential labels for NMR based
DNA and RNA secondary structure probing (28) is
lacking to date and represents a major goal here. This
includes a critical assessment of the impact of these
ﬂuorine modiﬁcations on DNA and RNA base pairing
properties. For such an undertaking, we considered
short bistable RNA and DNA oligonucleotides to be the
most appropriate systems (29–34). Bistable nucleic acids
are highly sensitive with respect to single nucleotide
mutations or chemical modiﬁcations since they directly
reﬂect the interference by a change of the secondary struc-
ture equilibrium position. We previously took advantage
of this sensitivity to explore the inﬂuence of nucleobase
methylations and to control switching of secondary
structures for a series of RNAs (30,31). Others extended
the latter concept by using photolabile chemical
modiﬁcations to study photochemically induced RNA
folding by real time NMR spectroscopy (33,35,36) and
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of short bistable oligonucleotides will directly reveal the
potential inﬂuence of 5-ﬂuoro pyrimidine labeling on sec-
ondary structure formation—if there is any.
MATERIALS AND METHODS
Synthesis of 5-ﬂuoro cytidine phosphoramidites (5 and 9)
General.
1H,
13C and
31P NMR spectra were recorded
on a Bruker DRX 300MHz, Avance II+ 600MHz or
Varian Unity 500MHz instrument. The chemical shifts
are referenced to the residual proton signal of the
deuterated solvents: CDCl3 (7.26ppm), d6-DMSO
(2.49ppm) for
1H NMR spectra; CDCl3 (77.0 ppm) or
d6-DMSO (39.5ppm) for
13C NMR spectra.
31P-shifts
are relative to external 85% phosphoric acid.
1H- and
13C-assignments were based on COSY and HSQC experi-
ments. UV-spectra were recorded on a Varian Cary 100
spectrophotometer. Analytical thin-layer chromatography
(TLC) was carried out on silica 60F-254 plates. Flash
column chromatography was carried out on silica gel 60
(230–400 mesh). All reactions were carried out under
argon atmosphere. Chemical reagents and solvents were
purchased from commercial suppliers and used without
further puriﬁcation. Organic solvents for reactions
were dried overnight over freshly activated molecular
sieves (4A ˚ ).
N
4-acetyl-5-ﬂuoro cytidine (2). A suspension of 5-ﬂuoro
cytidine 1 (300mg, 1.149mmol) in anhydrous ethanol
(12ml) was treated with acetic anhydride (1.7ml,
13.78mmol) and stirred for 14h at room temperature.
After evaporation of the solvent, the product was
coevaporated three times with diethylether and dried
under high vacuum. The crude product was then sus-
pended in 5ml diethylether, ﬁltrated and washed
thoroughly with ether. Yield: 346mg of 2 as white
powder (99%). TLC (CH2Cl2/CH3OH, 9/1): Rf=0.17;
1H NMR (300MHz, DMSO):   2.20 (s, 3H, COCH3);
3.59 [m, 1H, H1–C(50)]; 3.75 [m, 1H, H2–C(50)]; 3.89 [m,
1H, H–C(40)]; 3.97 [m, 2H, H–C(30)+H–C(20)]; 4.98 [m,
1H, HO–C(20) or HO–C(30)]; 5.29 [m, 1H, HO–C(50)]; 5.49
[m, 1H, HO–C(30) or HO–C(20)]; 5.67 [s, 1H, H–C(10)];
8.65 [d, J=6.6Hz, 1H, H–C(6)]; 10.52 [s, br, 1H,
HN–C(4)] ppm;
13C NMR (75MHz, DMSO):   25.24
(COCH3); 60.00 [C(50)]; 68.81, 75.11 [C(30), C(20)]; 84.67
[C(40)]; 90.92 [C(10)]; 130.39; 130.85; 135.99; 139.21;
153.03; 153.91; 170.12 (COCH3)ppm; UV/Vis (MeOH):
l (e)=260 (5100)nm (mol
 1dm
3cm
 1); ESI-MS (m/z):
[M+H]
+ calculated for C11H14FN3O6, 304.25; found
304.09.
N
4-acetyl-50-O-(4,40-dimethoxytrityl)-5-ﬂuoro cytidine
(3). To a suspension of N
4-acetyl-5-ﬂuoro cytidine 2
(121mg, 0.383mmol) in pyridine (1.5ml) was added 4,40-
dimethoxytritylchloride (143mg, 0.421mmol) in three
portions over a period of 1h. The reaction mixture was
stirred for 14h at room temperature, evaporated and
coevaporated with toluene and dichloromethane. The
crude product was puriﬁed by column chromatography
on SiO2 (CH2Cl2/CH3OH, 99/1–97/3 v/v). Yield: 144mg
of 3 as white foam (60%). TLC (CH2Cl2/CH3OH, 9/1):
Rf=0.50;
1H NMR (300MHz, CDCl3):   2.64 (s, 3H,
COCH3); 3.34 [dd, J=2.4, 11.1Hz, 1H, H1–C(50)]; 3.40
[dd, J=2.4, 11.1Hz, 1H, H2–C(50)]; 3.58 [s, br, 1H,
HO–C(30)]; 3.78, 3.79 (2s, 6H, 2  OCH3); 4.40 [m, 1H,
H–C(40)]; 4.48 [m, 1H, H–C(30)]; 4.53 [m, 1H, H–C(20)];
5.62 [s, br, 1H, HO–C(20)]; 5.79 [d, J=3.9Hz, 1H, H–
C(10)]; 6.82 [m, 4H, H–C(ar)]; 7.25 [m, 9H, H–C(ar)];
8.02 [s, br, 1H, HN–C(4)]; 8.11 [d, J=5.7Hz, 1H,
H–C(6)] ppm;
13C NMR (75MHz, CDCl3):   26.12
(COCH3); 55.18 (2  OCH3); 62.88 [C(50)]; 72.00 [C(30)];
77.04 [C(20)]; 86.14 [C(40)]; 87.18; 93.39 [C(10)]; 113.27,
113.32 [C(ar)]; 127.03 [C(ar)]; 127.79, 127.97 [C(ar)];
128.43, 128.88; 129.79, 129.91 [C(ar)]; 134.90, 134.28
[C(ar)]; 144.04 [C(ar)]; 149.64; 152.60; 152.75; 154.09;
158.63; 158.68; 170.87 (COCH3)ppm; UV/Vis (MeOH):
l (e)=260 (5400)nm (mol
 1dm
3cm
 1); ESI-MS (m/z):
[M+H]
+ calculated for C32H32FN3O8, 606.62; found
606.06.
N
4-acetyl-20-O-(tert.-butyldimethylsilyl)-50-O-(4,40-dimet-
hoxytrityl)-5-ﬂuoro cytidine (4a) and N
4-acetyl-30-O-
(tert.-butyldimethylsilyl)-50-O-(4,40-dimethoxytrityl)-5-
ﬂuoro cytidine (4b). Compound 3 (565mg, 0.933mmol)
and silver nitrate (285mg, 1.679mmol) was stirred in
THF (3.9ml) and pyridine (0.4ml) overnight at room tem-
perature. Then, tert.-butyldimethylchlorosilane (253mg,
1.679mmol) was added and stirring was continued for
Figure 1. Chemical structure of Watson–Crick base pairs in DNA and RNA with potential positions for non-invasive ﬂuoro labeling as indicated.
While ribose 20-ﬂuoro labels were evaluated for RNA secondary structure probing previously in our laboratory (42), the present study is focused on
a comprehensive comparison of 5-ﬂuoro pyrimidine labeling for both DNA and RNA structure probing by
19F NMR spectroscopy.
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the solvents were evaporated and the residue was
coevaporated with dichloromethane. The crude product
was puriﬁed by column chromatography on SiO2
(hexane/ethylacetate, 6/4 – 5/5 v/v). Yield: 325mg of 4a
(48%) and 95mg of 4b (14%) as white foam. TLC
(hexane/ethylacetate, 3/7): Rf (4a)=0.50, Rf (4b)=0.24;
1H NMR (300 MHz, CDCl3): 4a:   0.23 (s, 3H, SiCH3);
0.34 (s, 3H, SiCH3); 0.96 [s, 9H, SiC(CH3)3]; 2.41 [d,
J=9.3 Hz, 1H, HO–C(30)]; 2.68 (s, br, 3H, COCH3);
3.57 [m, 2H, H2-C(50)]; 3.80 [s, 6H, 2  OCH3]; 4.12 [m,
1H, H–C(40)]; 4.40 [m, 1H, H–C(20)]; 4.45 [m, 1H,
H–C(30)]; 5.77 [s, 1H, H–C(10)]; 6.85 [d, J=8.7Hz, 4H,
H–C(ar)]; 7.23–7.44 [m, 9H, H–C(ar)]; 7.81 [s, br, 1H,
HN–C(4)]; 8.38 [d, J=4.5Hz, 1H, H–C(6)] ppm; 4b: d
0.00 (s, 3H, SiCH3); 0.09 (s, 3H, SiCH3); 0.87 [s, 9H,
SiC(CH3)3]; 2.71 (s, br, 3H, COCH3); 3.13 [s, br, 1H,
HO–C(20)]; 3.33 [dd, J=3.0, 9.0Hz 1H, H1–C(50)]; 3.58
[m, 1H, H2–C(50)]; 3.82 (s, 6H, 2  OCH3); 4.18 [m, 1H,
H–C(40)]; 4.22 [m, 1H, H–C(20)]; 4.37 [m, 1H, H–C(30)];
5.96 [d, J=3.0Hz, 1H, H–C(10)]; 6.86 [d, J=9.0Hz, 4H,
H–C(ar)]; 7.25–7.40 [m, 9H, H–C(ar)]; 7.58 [s, br, 1H,
HN–C(4)]; 8.25 [m, 1H, H–C(6)] ppm;
13C NMR
(75MHz, CDCl3): 4a:   5.23,  4.19 (2  SiCH3); 18.22
[(SiC(CH3)3]; 25.98 [SiC(CH3)3]; 26.43 (COCH3); 55.37
(2  OCH3); 61.32 [C(50)]; 69.22 [C(30)]; 67.57 [C(20)];
83.45 [C(40)]; 87.32; 91.09 [C(10)]; 113.47, 133.51 [C(ar)];
127.21 [C(ar)]; 128.12, 128.16 [C(ar)]; 128.46; 130.13,
130.19 [C(ar)]; 135.23, 135.48, 144.43 [C(ar)]; 152.66;
152.81; 158.83; 158.87; 171.64 (COCH3)ppm; UV/Vis
(MeOH): 4a: l (e)=260 (5500)nm (mol
 1dm
3cm
 1);
ESI-MS (m/z): 4a:[ M + H ]
+ calculated for
C38H46FN3O8Si, 720.88; found 720.21; 4b:[ M + H ]
+
calculated for C38H46FN3O8Si, 720.88; found 720.23.
N
4-acetyl-20-O-(tert.-butyldimethylsilyl)-50-O-(4,40-dimet-
hoxytrityl)-5-ﬂuoro cytidine 30-(2-cyanoethyl)-N,N-
diisopropylphosphoramidite (5). Compound 4a (251mg,
0.349mmol) was dissolved in a mixture of N-ethyldiiso-
propylamine (597ml, 3.487mmol) and 1-methylimidazole
(138ml, 1.743mmol) in dichloromethane (5.4ml). After
15min at room temperature, (2-cyanoethyl)-N,N-
diisopropyl-chlorophosphoramidite (166mg, 0.697mmol)
was added slowly and the solution was stirred at room
temperature for 2.5h. Then, the solvent was evaporated,
the residue was coevaporated with dichloromethane and
dried on high vacuum. The crude product was puriﬁed
by column chromatography on SiO2 [hexane/ethylacetate,
7/3 – 5/5 v/v (+0.5% NEt3)]. Yield: 186mg of 5 (mixture
of diastereomers) as white foam (58%). TLC (hexane/
ethylacetate, 3/7): Rf=0.57, 0.45;
1H NMR (600MHz,
CDCl3):   0.16, 0.28 (2s, 12H, 4  SiCH3); 0.91, 0.92
(2s, 18H, 2  [SiC(CH3)3]; 1.00–1.16 {m, 24H, 2 
[(CH3)2CH]2N}; 2.42, 2.60 (2m, 4H, 2  CH2CN); 2.68
(s, br, 6H, 2  COCH3); 3.48–3.90 {m, 12H, 2 
[(CH3)2CH]2N, 2  H2–C(50), 2  POCH2}; 3.80 (s, 12H,
4  OCH3); 4.34–4.37 [m, 4H, 2  H–C(30)+2  H–C(40)];
4.47 [m, 2H, 2  H–C(20)]; 4.67, 4.75 [2m, 2H, 2  H–
C(10)]; 6.81–6.85 [m, 8H, H–C(ar)]; 7.23–7.47 [m, 18H,
H–C(ar)]; 8.37, 8.42 [2m, 2H, 2  H–C(6)] ppm;
31P
NMR (121MHz, CDCl3):   149.2, 151.5ppm; UV/Vis
(MeOH): l (e)=260 (5700)nm (mol
 1dm
3cm
 1); ESI-
MS (m/z): [M+H]
+ calculated for C47H63FN5O9PSi,
921.10; found 920.24.
N
4-benzoyl-5-ﬂuoro cytidine (6). A suspension of 5-ﬂuoro
cytidine 1 (100mg, 0.383mmol) in anhydrous ethanol
(4ml) was treated with benzoic anhydride (1.04g,
4.594mmol) and stirred for 14h at room temperature.
After evaporation of the solvent, the product was
coevaporated three times with diethylether and dried
under high vacuum. The crude product was then sus-
pended in 2ml diethylether, ﬁltrated and washed
thoroughly with ether. Yield: 134mg of 6 as white
powder (99%). TLC (CH2Cl2/CH3OH, 90/10):
Rf=0.40;
1H NMR (300MHz, DMSO):   3.63 [m, 1H,
H1–C(50)]; 3.74 [m, 1H, H2–C(50)]; 3.91 [m, 1H, H–C(40)];
4.04 [m, 2H, H–C(30)+H–C(20)]; 5.05 [m, 1H, HO–C(20)
or HO–C(30)]; 5.32 [m, 1H, HO–C(50)]; 5.51 [m, 1H, HO–
C(30) or HO–C(20)]; 5.74 [s, 1H, H–C(10)]; 7.51 [m, 2H,
H–C(ar)]; 7.62 [m, 1H, H–C(ar)]; 7.99 [m, 2H, H–C(ar)];
8.61 [m, 1H, H–C(6)]; 11–12.5 [s, br, 1H, HN–C(4)]ppm;
13C NMR (75MHz, DMSO):   60.30 [C(50)]; 69.21, 74.90
[C(30), C(20)]; 85.00 [C(40)]; 90.37 [C(10)]; 129.11–129.85
[C(ar), C(6)]; 133.47 [C(ar)]; 137.59; 140.73ppm; UV/Vis
(MeOH): l (e)=260 (1300)nm (mol
 1dm
3cm
 1); ESI-
MS (m/z): [M+H]
+ calculated for C15H16FN3O6,
366.32; found 366.03.
N
4-Benzoyl-50-O-(4,40-dimethoxytrityl)-5-ﬂuoro cytidine
(7). To a suspension of N
4-benzoyl-5-ﬂuoro cytidine 6
(247mg, 0.676mmol) in pyridine (2.6ml) was added 4,40-
dimethoxytritylchloride (252mg, 0.744mmol) in three
portions over a period of 1h. The reaction mixture was
stirred for 14h at room temperature, evaporated and
coevaporated with toluene and dichloromethane. The
crude product was puriﬁed by column chromatography
on SiO2 (CH2Cl2/CH3OH, 99/1 – 97/3 v/v). Yield:
251mg of 7 as white foam (56%). TLC (CH2Cl2/
CH3OH, 9/1): Rf=0.60;
1H NMR (300MHz, CDCl3):  
1.85 [s, br, 1H, HO–C(20)]; 3.42 [m, 2H, H2–C(50)]; 3.61 [s,
br, 1H, HO–C(30)]; 3.76, 3.77 (2s, 6H, 2  OCH3); 4.37 [m,
1H, H–C(40)]; 4.48 [m, 1H, H–C(30)]; 4.57 [m, 1H, H–
C(20)]; 5.85 [d, J=3.6Hz, 1H, H–C(10)]; 6.84 [m, 4H,
H–C(ar)]; 7.19–7.43 [m, 9H, H–C(ar)]; 7.48 [m, 2H,
H–C(ar)]; 7.57 [m, 1H, H–C(ar)]; 8.07 [m, 1H, H–C(6)];
8.16 [m, 2H, H–C(ar)]ppm;
13C NMR (75MHz, CDCl3):
  55.20 (2  OCH3); 62.89 [C(50)]; 71.76 [C(30)]; 76.68
[C(20)]; 85.71 [C(40)]; 87.40; 92.39 [C(10)]; 113.33, 113.36
[C(ar)]; 127.08 [C(ar)]; 127.88, 128.03 [C(ar)]; 128.48
[C(ar)]; 129.83, 129.98 [C(ar)]; 133.13 [C(ar)]; 135.02,
135.37 [C(ar)]; 144.08 [C(ar)]; 158.67, 158.70 [C(ar)]ppm;
UV/Vis (MeOH):   (e)=260 (2200)nm (mol
 1dm
3
cm
 1); ESI-MS (m/z): [M+H]
+ calculated for
C37H34FN3O8, 668.69; found 668.15.
N
4-benzoyl-20-O-(tert.-butyldimethylsilyl)-50-O-(4,40-dime-
thoxytrityl)-5-ﬂuoro cytidine (8a) and N
4-benzoyl-30-O-
(tert.-butyldimethylsilyl)-50-O-(4,40-dimethoxytrityl)-5-
ﬂuoro cytidine (8b). Compound 7 (251mg, 0.376mmol)
and silver nitrate (115mg, 0.677mmol) was stirred in
THF (1.5ml) and pyridine (0.15ml) overnight at room
7730 Nucleic Acids Research, 2009,Vol.37, No. 22temperature. Then, tert.-butyldimethylchlorosilane
(102mg, 0.677mmol) was added and stirring was con-
tinued for 1h. The resulting white suspension was
ﬁltered, the solvents were evaporated and the residue
was coevaporated with dichloromethane. The crude
product was puriﬁed by column chromatography on
SiO2 (hexane/ethylacetate, 8/2 – 7/3 v/v). Yield: 171mg
of 8a (58%) and 21mg of 8b (7%) as white foam. TLC
(hexane/ethylacetate, 7/3): Rf (8a)=0.50, Rf (8b)=0.26;
1H NMR (300MHz, CDCl3): 8a:   0.20 (s, 3H, SiCH3);
0.21 (s, 3H, SiCH3); 0.96 [s, 9H, SiC(CH3)3]; 2.64 [m, 1H,
HO–C(30)]; 3.52 [m, 2H, H2–C(50)]; 3.82 (s, 6H, 2 
OCH3); 4.18 [m, 1H, H–C(40)]; 4.39 [m, 1H, H–C(30)];
4.46 [m, 1H, H–C(20)]; 5.98 [d, J=2.7Hz, 1H, H–C(10)];
6.88 [d, J=8.1Hz, 4H, H–C(ar)]; 7.23 – 7.49 [m, 11H,
H–C(ar)]; 7.57 [m, 1H, H–C(ar)]; 8.11 [d, J=5.7Hz,
1H, H–C(6)]; 8.29 [d, J=7.2Hz, 2H, H–C(ar)]; 13.04
[s, br, 1H, HN–C(4)] ppm; 8b:   0.00 (s, 3H, SiCH3);
0.09 (s, 3H, SiCH3); 0.88 [s, 9H, SiC(CH3)3]; 2.84
[m, 1H, HO–C(20)]; 3.36 [dd, J=2.7, 11.1Hz, 1H,
H1–C(50)]; 3.51 [dd, J=2.1, 11.1Hz, 1H, H2–C(50)];
3.80 (s, 6H, 2  OCH3); 4.10 [m, 1H, H–C(40)]; 4.25 [m,
1H, H–C(20)]; 4.33 [m, 1H, H–C(30)]; 5.98 [d, J=3.0Hz,
1H, H–C(10)]; 6.86 [d, J=8.7Hz, 4H, H–C(ar)]; 7.25–7.48
[m, 11H, H–C(ar)]; 7.55 [m, 1H, H–C(ar)]; 8.00
[d, J=5.7Hz, 1H, H-C(6)]; 8.28 [d, J=7.5Hz, 2H,
H–C(ar)]; 13.01 [s, br, 1H, HN–C(4)]ppm;
13C NMR
[75MHz, CDCl3]: 8a:   5.02,  4.50 (2  SiCH3); 18.17
[SiC(CH3)3]; 25.82 [SiC(CH3)3]; 55.41 (2  OCH3); 62.68
[C(50)]; 70.93 [C(30)]; 76.59 [C(20)]; 84.07 [C(40)]; 87.54;
89.35 [C(10)]; 113.55, 133.58 [C(ar)]; 125.68; 127.33
[C(ar)]; 127.92, 127.98, 128.09, 128.24, 128.45, 129.28,
130.18, 133.17 [C(ar)]; 135.12; 135.39; 144.36;152.60;
152.85; 158.91, 158.93 [C(ar)] ppm; UV/Vis (MeOH):
8a: l (e)=260 (2900)nm (mol
 1dm
3cm
 1); ESI-MS
(m/z): 8a:[ M + H ]
+ calculated for C43H48FN3O8Si,
782.95; found 782.16; 8b:[ M + H ]
+ calculated for
C43H48FN3O8Si, 782.95; found 782.21.
N
4-benzoyl-20-O-(tert.-butyldimethylsilyl)-50-O-(4,40-dime-
thoxytrityl)-5-ﬂuoro cytidine 30-(2-cyanoethyl)-N,N-
diisopropylphosphoramidite (9). Compound 8a (125mg,
0.160mmol) was dissolved in a mixture of N-ethyldiiso-
propylamine (185ml, 1.60mmol) and 1-methylimidazole
(37ml, 0.800mmol) in dry dichloromethane (2.5ml).
After 15min at room temperature, (2-cyanoethyl)-N,N-
diisopropyl-chlorophosphoramidite (74mg, 0.320mmol)
was added slowly and the solution was stirred at room
temperature for 2.5h. Then, the solvent was evaporated,
the residue was coevaporated with dichloromethane and
dried on high vacuum. The crude product was puriﬁed
by column chromatography on SiO2 [hexane/ethylacetate,
7/3 v/v (+0.5% NEt3)]. Yield: 90 mg of 9 (mixture of
diastereomers) as white foam (57%). TLC (hexane/
ethylacetate, 7/3): Rf=0.47;
1H NMR (600MHz,
CDCl3):   0.13, 0.14, 0.15, 0.16 (4s, 12H, 4  SiCH3);
0.92, 0.93 [2s, 18H, 2  SiC(CH3)3]; 1.05–1.26 {m, 24H,
2  [(CH3)2CH]2N}; 2.40, 2.64 (2m, 4H, 2  CH2CN);
3.45 [m, 4H, 2  H2–C(50)]; 3.57–3.61 {m, 5H, 2 
[(CH3)2CH]2N+1  POCH(1)dia1}; 3.73 [m, 1H, 1 
POCH(1)dia2]; 3.798, 3.804 (2s, 12H, 4  OCH3); 3.84
[m, 1H, 1  POCH(2)dia1]; 3.95 [m, 1H, POCH(2)dia2];
4.26–4.35 [m, 4H, 2  H–C(30) and H–C(40)]; 4.46, 4.54
[2m, 2H, 2  H–C(20)]; 5.91, 6.00 [2d, J=4.2Hz, 2H,
2  H–C(10)]; 6.84–6.87 [m, 8H, H–C(ar)]; 7.23–7.53 [m,
22H, H–C(ar)]; 7.54 [m, 2H, H–C(ar)]; 8.07, 8.14 [2d,
J=6.0Hz, 2H, 2  H–C(6)]; 8.28 [d, J=7.8Hz, 4H,
H–C(ar)] ppm;
31P NMR (121MHz, CDCl3):   150.4,
150.9ppm; UV/Vis (MeOH): l (e)=260 (2400)nm
(mol
 1dm
3cm
 1); ESI-MS (m/z): [M+H]
+ calculated
for C52H65FN5O9PSi, 983.17; found 982.12.
Solid-phase synthesis of oligonucleotides
20-O-TOM standard nucleoside phosphoramidites were
obtained from GlenResearch or ChemGenes. 20-O-tert.-
Butyldimethylsilyl-50-O-(4,40-dimethoxytrityl)-5-ﬂuoro
uridine phosphoramidite was purchased from
ChemGenes,50-O-(4,40-dimethoxytrityl)-5-ﬂuoro20-deoxy-
uridine phosphoramidite and 50-O-(4,40-dimethoxytrityl)-
5-ﬂuoro-O
4-(2,4,6-trimethylphenyl) 20-deoxyuridine
phosphoramidite were obtained from GlenResearch. All
solid supports for DNA and RNA synthesis were
purchased from GE Healthcare (Custom Primer
Supports: riboC Ac 80, riboA 80, riboG 80, riboU 80;
dA 80s, dC 80s, dG 80s, T 80s). All oligonucleotides
were synthesized on Pharmacia instruments (Gene
Assembler Plus) following DNA/RNA standard
methods; detritylation (2.0min): dichloroacetic acid/1,2-
dichloroethane (4/96); coupling (3.0min): phosphor-
amidites/acetonitrile (0.1M 120ml) were activated by
benzylthiotetrazole/acetonitrile (0.35M 360ml); capping
(3 0.4min): A: Ac2O/sym-collidine/acetonitrile (20/30/
50), B: 4-(dimethylamino)pyridine/acetonitrile (0.5M),
A/B=1/1; oxidation (1.0min): I2 (10mM) in aceto-
nitrile/sym-collidine/H2O (10/1/5). Solutions of standard
amidites, tetrazole solutions and acetonitrile were dried
over activated molecular sieves overnight. Solutions of 5-
ﬂuoro pyrimidine modiﬁed phosphoramidites were only
dried for 4–6h over molecular sieves before consumption.
Deprotection of oligonucleotides
DNA oligonucleotides were deprotected by treatment with
ammonia in water (32%) and ethanol (ﬁnal volume 1ml,
aqueous ammonia/ethanol 3/1, v/v) at 55 C for 16h. The
solution was evaporated to dryness and the crude
oligonucleotide was dissolved in 1.0ml of water. RNA
oligonucleotides (including those containing N
4-acetyl
protected C
5F) were deprotected by using MeNH2 in
EtOH (8M, 0.60ml) and MeNH2 in H2O (40%, 0.60ml)
at room temperature for 5–6h. After complete evapora-
tion of the solution, the 20-O-TOM protecting groups were
removed by treatment with tetrabutylammonium ﬂuoride
trihydrate (TBAF 3H2O) in THF (1M, 0.95ml) for at
least 12h at 37 C. The reaction was quenched by
addition of triethylammonium acetate (TEAA) (1M, pH
7.0, 0.95ml). The volume of the solution was reduced to
1ml and the solution was loaded on a GE Healthcare
HiPrep 26/10 Desalting column (2.6 10 cm; Sephadex
G25). The crude RNA was eluted with H2O, evaporated
to dryness and dissolved in 1.0ml of water.
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Analysis of crude oligonucleotides after deprotection was
performed by anion-exchange chromatography on a
Dionex DNAPac100 column (4 250 mm) at 80 C.
Flow rate: 1mlmin
 1; eluant A: 25mM Tris–HCl (pH
8.0), 6M urea; eluant B: 25mM Tris–HCl (pH 8.0),
0.5M NaClO4, 6M urea; gradient: 0–40% B in A within
30min (<20nt) or 0–60% B in A within 45min (>20nt);
UV-detection at 265nm. Crude RNA products (trityl-oﬀ)
were puriﬁed on a semipreparative Dionex DNAPac100
column (9 250mm). Flow rate: 2mlmin
 1; gradient:
 5–10% B in A within 20min. Fractions contain-
ing oligonucleotide were loaded on a C18 SepPak car-
tridge (waters/millipore), washed with 0.1–0.2M
(Et3NH)
+HCO3  and H2O, eluted with H2O/CH3CN
and lyophilized to dryness. The puriﬁed oligonucleotides
were characterized by mass spectrometry on a Finnigan
LCQ Advantage MAX ion trap instrumentation con-
nected to an Amersham Ettan micro LC system
(negative-ion mode with a potential of  4kV applied to
the spray needle). LC: Sample (250pmol of oligo-
nucleotide dissolved in 20ml of 20mM EDTA solution;
average injection volume: 10–20ml); column (Amersham
mRPC C2/C18; 2.1 100mm) at 21 C; ﬂow rate:
100mlmin
 1; eluant A: 8.6mM TEA, 100mM 1,1,1,3,3,
3-hexaﬂuoro-2-propanol in H2O (pH 8.0); eluant B:
methanol; gradient: 0–100% B in A within 30 min; UV
detection at 254nm.
NMR spectroscopy
19F NMR spectra with
1H-decoupling were recorded
at a frequency of 564.7MHz on a Bruker Avance
II+600MHz NMR spectrometer equipped with a 5mm
QNP probe. Typical experimental parameters were chosen
as follows: spectral width 5.647kHz,
19F excitation pulse
12.4ms, acquisition time 1.0s, relaxation delay 2s, number
of scans 2K, proton decoupling using Waltz-16 with
gB1=1kHz. Prior to Fourier transformation all time
domain data was processed with an exponential window
function using a line broadening factor of 2Hz.
19F-
resonances were referenced relative to external CCl3F.
Sample preparation: oligonucleotides (triethylammonium
salts) together with the adequate amount of sodium
arsenate buﬀer were lyophilized to dryness, and
subsequently dissolved in H2O/D2O (9/1, v/v, 500ml). All
samples were heated to 90 C for 2min, then cooled to
room temperature and equilibrated for one hour before
measurements.
RESULTS AND DISCUSSION
Synthesis of 5-ﬂuoro pyrimidine containing DNA and RNA
All oligonucleotides investigated here were chemically
synthesized by solid-phase synthesis. For 5-ﬂuoro
pyrimidine (dU
5F or dC
5F) modiﬁed DNA, we used the
commercially available building blocks of either 50-O-
(4,40-dimethoxytrityl)-5-ﬂuoro 20-O-deoxyuridine 30-[(2-
cyanoethyl)-(N,N-diisopropyl)]phosphoramidite or 50-O-
(4,40-dimethoxytrityl)-5-ﬂuoro-O
4-(2,4,6-trimethylphenyl)
20-deoxyuridine 30-[(2-cyanoethyl)-(N,N-diisopropyl)]
phosphoramidite (26). The latter was converted into
5-ﬂuoro 20-deoxycytidine after oligonucleotide synthesis
by ammonium hydroxide used for the routine
deprotection steps. For 5-ﬂuoro uridine (U
5F) modiﬁed
RNA, we applied commercially available 20-O-(tert.
-butyldimethylsilyl)-50-O-(4,40-dimethoxytrityl)-5-ﬂuoro
uridine 30-[(2-cyanoethyl)-(N,N-diisopropyl)]phosphora-
midite (6,23). For the preparation of 5-ﬂuoro cytidine
(C
5F) modiﬁed RNAs, we elaborated a short synthetic
route towards 5-ﬂuoro cytidine phosphoramidites
equipped for solid-phase synthesis (Scheme 1). Up to
now, 5-ﬂuoro cytidine containing RNAs have been
provided mostly by enzymatic methods, producing
uniformly 5-ﬂuoro cytidine labeled derivatives (24,25), or
by chemical solid-phase synthesis using a convertible
5-ﬂuoro-O
4-methyl uridine nucleoside (6). Ammonolysis
has been required to convert the uridine precursor into
the corresponding cytidine nucleoside after completed
strand assembly (NH3/MeOH, r.t., 80h) (6). The severe
limitations of ammonolysis for the deprotection of larger
chemically synthesized RNA strands prompted us to
develop a synthetic route for the straightforward incorpo-
ration of 5-ﬂuoro cytidine into RNA.
Facile synthesis of a 5-ﬂuoro cytidine phosphoramidite
derivative and incorporation into RNA
The synthesis started with commercially available 5-ﬂuoro
cytidine 1 using acetic anhydride in anhydrous ethanol
for acetylation at C(4)–NH2 to obtain compound 2
(Scheme 1). In analogy, the usage of benzoic anhydride
resulted in derivative 6. After regioselective protection of
the 50-OH with the 4,40-dimethoxytrityl group under
standard conditions to yield compounds 3 and 7, respec-
tively, the 20 hydroxy group was reacted with tert.-
butyldimethylchlorosilane in the presence of silver
nitrate. The resulting derivatives 4a and 8a, respectively,
were ﬁnally converted into phosphoramidite 5 and 9 by
reaction with (2-cyanoethyl)-N,N-diisopropylchloropho-
sphoramidite in the presence of 1-methylimidazole and
N-ethyldiisopropylamine in dichloromethane. This route
provided compound 5 in a 17% overall yield and
compound 9 in a 14% overall yield in four steps with
three chromatographic puriﬁcations. In total, 0.7g of 5
and 0.4g of 9 were prepared in the course of this study.
These building blocks were incorporated into RNA by
solid-phase synthesis with >98% coupling eﬃciencies.
Importantly, deprotection of RNA containing N
4-acetyl-
5-ﬂuoro cytidine was accomplished under standard
conditions using methylamine in H2O/EtOH whereas
deprotection of the N
4-benzoyl protected counterpart
required treatment with aqueous ammonia prior to appli-
cation of methylamine to circumvent potential substitu-
tion of the phenyl carboxamide moiety at C(4) by
methylamine. Because of this, we preferred the prepa-
ration of 5-ﬂuoro cytidine modiﬁed RNAs using the
N
4-acetyl protection concept.
The molecular weights of all 5-ﬂuoro substituted DNA
and RNA oligonucleotides synthesized in this study were
conﬁrmed by LC-ESI mass spectrometry (Table 1).
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Bistable nucleic acids exist in dynamic equilibria between
two deﬁned secondary structures (29). We have previously
shown this behavior for a series of rationally designed
oligoribonucleotides (29–31) and we also demonstrated
the applicability of 20-ﬂuoro ribose labeling to probe the
secondary structures of bistable RNA (42). The intention
of the present study is on the one hand, to introduce
bistable DNA oligonucleotides and on the other hand,
Scheme 1. Synthesis of 5-ﬂuoro cytidine phosphoramidites 5 and 9;( a) 12 eq. acetic anhydride (for 2) or benzoic anhydride (for 6) in anhydrous
ethanol, room temperature, 14h, 99% (2) and 99% (6); (b) 1.1 eq. 4,40-dimethoxytrityl chloride in pyridine, room temperature, 14h, 60% (3) and
56% (7); (c) 1.8 eq. silver nitrate, 1.8 eq. tert.-butyldimethylchlorosilane in tetrahydrofurane/pyridine, room temperature, 15h, 48% (4a) and 58%
(8a) (yields after separation from 4b and 8b, respectively); (d) 2 eq. (2-cyanoethyl)-N,N-diisopropylchlorophosphoramidite, 10 eq. N-ethyldiiso-
propylamine, 5 eq. 1-methylimidazole in dichloromethane, room temperature, 2.5h, 58% (5) and 57% (9).
Table 1. Selection of chemically synthesized 5-ﬂuoro uracil and 5-ﬂuoro cytosine modiﬁed DNA and RNA oligonucleotides
a
No. Sequence
a Length Isolated yield Molecular weight
(nt) OD 260 nm (nmol) Calculated (amu) Found
b (amu)
S2 50-d(TCG TAC CGG AAG GTA CGA ACC dU
5FTC CG)-30 26 88 320 7960.1 7958.8
S2b 50-d(CCG GAA GGT ACG AAC CdU
5FT CCG)-30 21 78 350 6420.1 6419.1
S4 50-r(GAC CGG AAG GUC CGC CU
5FU CC)-30 20 68 320 6374.8 6374.9
S4b 50-r(CGG AAG GUC CGC CU
5FU CC)-30 17 86 500 5395.2 5394.8
S5 50-r(GAC CGG AAG GUC CGC CU
5FU
5F CC)-30 20 66 323 6392.8 6393.1
S5b 50-r(CGG AAG GUC CGC CU
5FU
5F CC)-30 17 27 161 5413.2 5412.8
S6 50-d(TCG TAC CGG AAG GTA CGA ACdC
5F TTC CG)-30 26 150 550 7974.1 7973.6
S6b 50-d(C CGG AAG GTA CGA ACdC
5F TTC CG)-30 21 93 420 6434.1 6433.0
S7 50-r(GAC CGG AAG GUC CGC C
5FUU CC)-30 20 64 310 6374.8 6373.5
S7b 50-r(CGG AAG GUC CGC C
5FUU CC)-30 17 64 370 5395.2 5394.7
adU
5F, 5-ﬂuoro 20-deoxy uridine; dC
5F, 5-ﬂuoro 20-deoxy cytidine; U
5F, 5-ﬂuoro uridine; C
5F, 5-ﬂuoro cytidine.
bLC-ESI MS.
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manner for both RNA and DNA secondary structure
probing. The previously applied 20-ﬂuoro ribose label
does not fulﬁll this requirement since this modiﬁcation
favors ribose C30-endo over C20-endo conformation and
therefore supports structural integrity of RNA only (11).
For these reasons, we focused on the assessment of
5-ﬂuoro pyrimidine labeling in the present comparative
study.
Rational design of bistable oligonucleotides
Following the sequence design of two haipins that
compete for the same internal sequence partition, we
demonstrated that a 26nt DNA with the sequence of 50-
TCG TAC CGG AAG GTA CGA ACC TTC CG-30 S1
exhibited a 70:30 (estimated accuracy ±10) structure equi-
librium between fold S10 and S100 (Figure 2A). This was
veriﬁed by comparative imino proton
1H NMR spectros-
copy with a set of shorter reference oligonucleotides
(S1a and S1b) that were corresponding to either of the
two potential folds. To the best of our knowledge, this
sequence is the ﬁrst example of a short DNA with pro-
nounced bistable secondary structure characteristics. For
the bistable RNA system, we relied on a previously
introduced 20nt RNA, 50-GAC CGG AAG GUC CGC
CUU CC-30 S3 that exhibited a 20:80 equilibrium between
fold S30 and S300 under the buﬀer conditions used
(Figure 3A, top) (30).
Bistable DNA and RNA with 5-ﬂuoro uracil labels
Alternative secondary structures of the same RNA
sequence can be distinguished by use of
19F NMR spec-
troscopy if a distinct 20-F modiﬁed nucleoside resides
within the double helix of 1-fold while it is part of a
single-stranded region within the alternative fold; we
demonstrated this aspect previously (42). However, since
20-F modiﬁed nucleosides are incompatible with the struc-
tural integrity of DNA as outlined above, we considered
that the chemical environment of a ﬂuorine atom attached
at C5 of 20-deoxyuridine should also be diﬀerent for
the two cases of double helical versus single-stranded
arrangements. We therefore expected diﬀerent chemical
shift values of the corresponding
19F NMR resonances.
In this sense, we replaced thymidine by 5-ﬂuoro
20-deoxyuridine in position 22 of S1 to yield S2 and
analyzed the respective modiﬁed bistable DNA
(Figure 2B). Indeed, the equilibrium position of S2,
analyzed by comparative imino proton
1H NMR spectros-
copy exhibited a 70:30 ratio between S20 and S200 and was
well comparable to that of the unmodiﬁed DNA S1.
Figure 2. Bistable 26 nt DNA oligonucleotide. (A) Imino proton
1H NMR spectra of bistable DNA S1 (existing in a dynamic equilibrium of
secondary structures S10 and S100) and of reference hairpins S1a and S1b.( B) Same for the 5-ﬂuoro 20-deoxyuridine modiﬁed bistable DNA S2 (S2’
and S200) and the corresponding reference hairpins S1a and S2b.( C)
1H decoupled
19F NMR spectra of S2 and the corresponding reference hairpin
S2b and reference single strand 50-d[ACC(dU
5F)TCCG]. Conditions: 0.3mM oligonucleotide, 25mM sodium arsenate buﬀer, H2O/D2O=9/1,
pH 7.0, 300K.
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19F NMR spectrum displayed
two individual resonances (separated by  0.35ppm) cor-
responding to the two secondary structures (Figure 2C).
The ratio determined on basis of the
19F NMR signals
was 70:30 and again in good agreement with the value
determined from the
1H NMR spectrum. Together, this
indicated that the inﬂuence of a single 5-ﬂuoro uracil
substituent on the DNA structure equilibrium was minor
and within the range of accuracy. Interestingly, the
19F
NMR resonance of 5-ﬂuoro uracil showed an increased
line width when it was involved in base pairing
compared to the situation when it was located in an
unpaired strand region. Moreover, we stress that the
1H
NMR spectra of the bistable DNA S2 as well as the
hairpin reference S2b were lacking the N(3)–H imino
proton resonances of the respective dA:dU
5F base pairs
at 300K (compare Figure 2A, top to Figure 2B, top;
and Figure 2A, bottom to Figure 2B, bottom). All other
imino protons showed similar chemical shift values as the
ones observed for the unmodiﬁed DNA counterparts,
S1 and S1b. Importantly, we observed the same
behavior for the 20nt bistable RNA S3 when one or
even two A:U base pairs were replaced by A:U
5F to
yield S4 and S5, respectively (Figure 3A). Again, at
300K, the
1H NMR imino proton resonance pattern of
S4 and S5 was lacking one or two signals, respectively,
that were attributed to 5-ﬂuoro substituted Watson–Crick
base pairs while all other imino protons provided chemical
shift values comparable to that of the unmodiﬁed RNA
counterpart. Our ﬁnding ﬁts to a report by James and
coworkers who showed in a temperature dependent
series of
1H NMR spectra for the self-complementary
duplex of [d(GGAAT(dU
5F)CC)]2 that the dU
5F N(3)–H
resonance is extremely broad at low temperatures and
becomes non-observable at room temperature (5). Also
Hennig et al., observed for a uniformly 5-ﬂuoro uridine
labeled HIV TAR hairpin signiﬁcant line broadening
of 5-ﬂuoro uridine N(3)–H imino protons together
with a downﬁeld chemical shift change between 0.6 and
0.7ppm (24). The line broadening most likely reﬂects an
increased exchange rate of dA:dU
5F and A:U
5F imino
protons and relates to the considerable electronegativity
of the 5-ﬂuorine atom that lowers the apparent pKa of
uridine N(3)–H from 9.18±0.02 (unmodiﬁed uridine) to
a value of 7.55±0.02 (5-ﬂuoro uridine) (43).
With respect to the structure equilibrium of the bistable
RNA S3 (S30:S300 =20:80), a single 5-ﬂuoro uridine sub-
stitution, as in S4, did not change the equilibrium ratio of
20:80 between S40 and S400, determined by
1H NMR and
19F NMR spectroscopy in independent manner (Figure 3B
Figure 3. Bistable 20nt RNA oligonucleotide. (A) Comparison of imino proton
1H NMR spectra of bistable RNA S3 (existing in a dynamic
equilibrium of secondary structures S30 and S300) and the single and double 5-ﬂuoro uridine modiﬁed derivatives S4 and S5, respectively. (B) Imino
proton
1H NMR spectra of S4 and of reference hairpins S4a and S4b.( C)
1H decoupled
19F NMR spectra of S4 and the corresponding reference
hairpin S4b and reference single strand 50-r(CGCC(U
5F)UCC). Conditions: 0.3mM oligonucleotide, 25mM sodium arsenate buﬀer, H2O/D2O=9/1,
pH 7.0, 300K.
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19F
resonances assigned for the RNA folds of S40 and S400
was 3.5ppm, and therefore remarkably larger compared
to the chemical shift diﬀerence of 0.35ppm observed for
the
19F resonances of the two DNA folds S20 and S200.
This most likely reﬂects the diﬀerent stacking patterns of
Watson–Crick base pairs within A- and B-form (Figure 4
and Supplementary Data) and moreover, the much more
pronounced diﬀerence in the chemical environment of a
5-ﬂuoro pyrimidine atom that resides within an RNA
duplex compared to its RNA single strand than the respec-
tive environments encountered for DNA.
Taken together, 5-ﬂuoro uracil represents a non-
invasive label for structural probing by
19F NMR spec-
troscopy of both, bistable DNA and RNA. This rationale
holds true even for double labeling; the bistable RNA
S5 which contained two successive 5-ﬂuoro uridine
replacements revealed only a marginally shifted equilib-
rium position for the two secondary structures of S50
and S500 (Figure 3C, bottom).
Bistable DNA and RNA with 5-ﬂuoro cytosine labels
The bistable DNA and RNA sequences, S1 and S3, were
labeled with single 5-ﬂuoro cytosines and—as their uracil
counterparts—turned out to be non-invasive labels.
The dC
5F at position 21 of DNA S6 resulted in an equi-
librium position between S60 and S600 of 70:30 (Figure 5A)
and was unchanged compared with the unmodiﬁed
counterpart DNA S1 (Figure 2A). Also for the C
5F
modiﬁed RNA S7, the determined equilibrium position
of 15:85 between S70 and S700 (Figure 5B) revealed that
the structure equilibrium was—within the limits of
Figure 5. 5-Fluoro cytidine modiﬁed bistable DNA and RNA oligonucleotides, S6 and S7.( A) Imino proton
1H NMR spectra of bistable DNA S6
(existing in a dynamic equilibrium of secondary structures S60 and S600) and of reference hairpins S1a and S6b.( B)
1H decoupled
19F NMR spectra
of S6 and the corresponding reference hairpin S6b and reference single strand 50-ACC
5FTTCCG. (C) Same as (A) for the 5-ﬂuoro cytidine modiﬁed
bistable RNA S7 (S70 and S700) and the corresponding reference hairpins S4a and S7b.( D) Same as (A) for S7 and the corresponding reference
hairpin S7b and reference single strand 50-CGCC
5FUUCC. Conditions: 0.3mM oligonucleotide, 25mM sodium arsenate buﬀer, D2O, pH 7.0, 300K;
(for spectra of 5-ﬂuoro cytidine labeled oligonucleotides in H2O/D2O = 9/1 see Supplementary Data).
Figure 4. Three-dimensional model for the chemical environment of
A:T and A:U base pairs in S100 and S300 assuming standard A- and
B-form, respectively. The position of ﬂuoro labeling is indicated by an
asterisk or the number 5 in red color. (A) DNA duplex with sequence
as indicated (side view). (B) Same as (A) (top view). (C) RNA duplex
with sequence as indicated (side view). (D) Same as (C) (top view).
For stereo views see Supplementary Data.
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counterpart S3 (Figure 3A).
For protonated 5-ﬂuoro cytidine, a signiﬁcantly lower
pKa value of pKa[N(3)–H
+]=2.3 was reported when
compared to their unmodiﬁed counterpart (pKa[N(3)–
H
+]=4.2) (44). However, opposed to the signiﬁcantly
broad shape of the imino proton resonances for
dA:dU
5F and A:U
5F base pairs, the imino protons of
dG:dC
5F and G:C
5F base pairs displayed the typical
linewidth for N–H   N signals at 300K. This observation
accords with the higher thermodynamic stability of G:C
versus A:U base pairs and therefore decreased N–H   N
exchange rates. In consent with a report by Henning et al.
(24), the guanine N(1)–H imino proton experienced a
slight shift upﬁeld when involved in base pairing with C
5F.
For the 5-ﬂuoro cytosine DNA and RNA series, we
observed a pronounced solvent induced isotope shift
eﬀect. Figure 6 depicts the typical signal pattern of a
dC
5F modiﬁed single-stranded DNA, 50-AC(dC
5F)TTCC
G, (Figures 5A and 6A) and of the hairpin S6b (dC
5F
involved in base pairing, Figure 6B) when the ratio
of H2O:D2O was gradually altered. Also for C
5F
modiﬁed RNAs we observed this eﬀect (see Supporting
Information). Solvent induced shifts of ﬂuorine
resonances have been previously reported for small
organic molecules as well as ﬂuorine labeled biomolecules
(45). In the case of 5-ﬂuoro cytidine modiﬁed
oligonucleotides, the appearance of additional signals
cannot only be attributed to solvent exposure of the
ﬂuorine nucleus but additionally stems from the isotopic
replacement of exchangeable protons within the exocyclic
amino group of the nucleobase (Figure 6C). A potential
intramolecular hydrogen bond between C(5)–F   H–
N(C4) may be the cause for this pronounced eﬀect and
would be consistent with the lack of this phenomenon in
the 5-ﬂuoro uracil series.
Inﬂuence of 5-ﬂuoro pyrimidine modiﬁcations on
thermodynamic stability
Since 5-ﬂuoro modiﬁcations left the equilibrium position
of bistable DNA and RNA unchanged, we expected their
impact on thermodynamic base pairing stability to be
minor. To provide evidence for this assumption, we
recorded UV melting curves of DNA hairpin references
S1b (unmodiﬁed), S2b (dU
5F) and S6b (C
5F) (Supple-
mentary Data). In aqueous buﬀer system of 150mM
NaCl and 10mM phosphate buﬀer, at pH 7.0 and at
2mM DNA concentration, their Tm values varied only
within 72.5±1.0 C and their thermodynamic stabilities
were in the small range of  G  =7.1±0.5kcalmol
 1.
The Tm values of the RNA hairpin references S3b
(unmodiﬁed), S4b (U
5F), S5b (U
5FU
5F) and S7b (C
5F)
also varied only within one degree, 75.5±1.0 C, and
their thermodynamic stabilities were within the range
of  G  =7.1±0.3kcalmol
 1. In extrapolation, these
thermal and thermodynamic data suggest that the
stabilities of the two competing hairpin structures in
bistable oligonucleotides are minimally aﬀected by the
5-ﬂuoro pyrimidine labels.
Pseudoknot formation of a riboswitch aptamer
To demonstrate the value of 5-ﬂuoro pyrimidine labeling
for biologically relevant RNAs, we monitored the forma-
tion of a riboswitch aptamer/ligand complex (Figure 7).
Based on the recently published X-ray and NMR
structures of a 7-aminomethyl-7-deazaguanine (preQ1)
sensing mRNA aptamer domain (46–49), we expected
that ﬂuorine labeling of U32 in the single-stranded
nucleotide 30-overhang (...C(5F–U32)AG-30) would
allow to follow base pairing with four complementary
nucleotides in the loop (double-helix formation). Indeed,
a signiﬁcant shift of the ﬂuorine resonance from 164.4 to
166.5ppm was observed upon ligand addition correspond-
ing to the free versus ligand-bound RNA (Figure 7).
Ongoing experiments focus on the veriﬁcation of ligand-
induced secondary structure rearrangements within the
expression platform of the full-length preQ1 riboswitch
domain containing single ﬂuorine labels.
CONCLUSIONS
With the present study, we demonstrated the reliability of
5-ﬂuoro labeling at pyrimidine nucleobases for secondary
structure probing by
19F NMR spectroscopy. For bistable
Figure 6. Solvent-induced isotope shift observed for 5-ﬂuoro cytidine
modiﬁed oligonucleotides. (A)
19F NMR spectra of 50-ACC
5FTTCCG
recorded in varying mixtures of H2O/D2O. (B) Same for DNA hairpin
S6b. Conditions: 0.3mM oligonucleotide, 25mM sodium arsenate
buﬀer, pH 7.0, 300K. (C) Deuterium exchange at the exocyclic
amino group of 5-ﬂuoro cytidine can result in four structures,
causing individually shifted
19F resonance signals that are diﬀerently
populated at diﬀerent H2O/D2O ratios.
Nucleic Acids Research, 2009,Vol.37, No. 22 7737DNA and RNAs, the impact of single 5-ﬂuoro pyrimidine
substitutions on the equilibrium position was within the
accuracy of determination. Watson–Crick base pairing
properties were preserved corresponding to the observa-
tion that thermodynamic stabilities remained unchanged
for the modiﬁed versus non-modiﬁed double helices.
5-ﬂuoro pyrimidine modiﬁcations hence turned out to be
non-invasive spin label options for secondary structure
evaluation by
19F NMR spectroscopy. This was not
expected in such strict manner, since the pKa values of
the N(3) imino proton of 5-ﬂuoro uracil and of N(3)
protonated 5-ﬂuoro cytosine are decreased by the order
of two. A change of pKa values could potentially aﬀect
base pair formation, in particular base pairing strength
because of higher proton mobility and higher proton
exchange rates with the solvent, and consequently could
aﬀect the RNA structure equilibrium. However, our study
showed that this concern did not come true.
In comparison with RNA 20-F ribose labeling that we
explored previously in our laboratory (42), 5-ﬂuoro
labeling is superior in one aspect: the modiﬁcation does
not directly aﬀect ribose puckering and is therefore appli-
cable for both DNA and RNA. However, we recall that
20-F ribose represents an ideal label if constitutionally
equivalent labeling of all four standard nucleosides is
required (42). We also recall that 20-F modiﬁed pyrimidine
nucleosides shifted the equilibrium position of bistable
RNAs by  25% (42) which can be regarded as disadvan-
tage compared to 5-F pyrimidine labeling. Only 20-F
modiﬁed purine nucleosides left the RNA equilibrium
position unchanged as observed here for the 5-ﬂuoro
pyrimidine series (42).
RNA with site-selective 5-F pyrimidine labels are
conveniently accessible by chemical solid-phase synthesis
for a size up to  65 nucleotides. Larger RNAs with site-
speciﬁc labels in nmol quantities that are required for
various types of biophysical experiments are accessible
by combined approaches using chemical synthesis
and enzymatic ligation methods as we have recently
exempliﬁed for adenine and TPP riboswitches containing
ﬂuorescent dyes (50–53). We consider the advantage
of site-speciﬁc 5-F pyrimidine labeling over fully 5-F
pyrimidine labeled RNA [which are eﬃciently prepared
biochemically (24,25)] in the avoidance of constitutional
assignments of
19F resonances and also in the avoidance of
signal overlaps that are likely to be encountered in the
fully labeled counterparts. We are conﬁdent that the use
of RNAs labeled with single ﬂuorine probes is a require-
ment to assist facile veriﬁcation of RNA secondary struc-
ture models and we are currently working along this line.
Taken together, we consider this study as an important
step on the way to identify reliable ﬂuoro labels for RNA
structure probing by NMR spectroscopy, with the long-
term aim to contribute to the elucidation of folding
pathways of biologically relevant, mid-sized RNA (up to
 200nt), such as riboswitches (49–52).
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